ReviewAdvanced materials (Deerfield Beach, Fla.)2026
Engineering Silk Fibroin-Based Biomaterials for Neural Repair.
Review in Advanced materials (Deerfield Beach, Fla.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Neurological injuries remain a major clinical challenge due to the limited regenerative capacity of neural tissue, the persistence of inhibitory post-injury microenvironments, and the lack of biomaterials capable of simultaneously providing structural support and biological instruction. Growing evidence highlights that biomaterial-mediated modulation of the neural microenvironment is essential for effective neural regeneration and functional recovery. Silk fibroin (SF), a naturally derived protein biomaterial, has attracted growing interest in neural repair owing to its tunable mechanical properties, controllable degradation, structural anisotropy, and versatile modification potential. Beyond serving as passive scaffolds, SF-based biomaterials actively regulate axonal guidance, neural and glial cell behavior, and neuroinflammatory responses. This review systematically summarizes the physicochemical properties and modification strategies of SF, elucidates the underlying mechanisms by which SF-based materials promote neural repair, and discusses diverse SF-based material formats, including hydrogels, scaffolds, patches, nanofibers, and nerve conduits. Representative applications in peripheral nerve injury and central nervous system disorders, such as spinal cord injury, traumatic brain injury, cerebral palsy, ischemic stroke, and Parkinson's disease, are highlighted. Finally, current challenges and future perspectives of SF-based neural biomaterials are discussed, with an emphasis on guiding the rational design and clinical translation of next-generation neural repair strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.